Chronic kidney disease kills more than 1M people annually worldwide
Chronic kidney disease has been described as a " global killer in plain sight " by the authors of a new analysis estimating the prevalence of the condition. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 14, 2020 Category: Consumer Health News Source Type: news

Study Identifies Drugs of Concern for Patients With CKD
A team of Canadian researchers has developed a list of three dozen medications that must or could be dose-adjusted or avoided in patients with chronic kidney disease. (Source: AAFP News)
Source: AAFP News - February 12, 2020 Category: Primary Care Source Type: news

This drug maker's kidney disease treatment scores $50M payday
FibroGen Inc. will receive $50 million from partner AstraZeneca after federal regulators accepted the San Francisco company's application to approve a drug for treating anemia in chronic kidney disease patients. Acceptance of FibroGen's new drug application for the drug, called roxadustat, by the Food and Drug Administration means AstraZeneca plc (NYSE: AZN) must pay $50 million to FibroGen, the company said in a Securities and Exchange Commission filing Tuesday. Roxadustat, an oral small-molecule… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 12, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

This drug maker's kidney disease treatment scores $50M payday
FibroGen Inc. will receive $50 million from partner AstraZeneca after federal regulators accepted the San Francisco company's application to approve a drug for treating anemia in chronic kidney disease patients. Acceptance of FibroGen's new drug application for the drug, called roxadustat, by the Food and Drug Administration means AstraZeneca plc (NYSE: AZN) must pay $50 million to FibroGen, the company said in a Securities and Exchange Commission filing Tuesday. Roxadustat, an oral small-molecule… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 12, 2020 Category: Biotechnology Authors: Ron Leuty Source Type: news

Link between chronic kidney disease and heart failure is identified in patients
(University of Alabama at Birmingham) People with chronic kidney disease have a higher risk for heart disease and heart-disease death. Now, for the first time in humans, researchers have identified a pathological change that appears to link kidney disease to progressive heart disease. This offers a potential treatment target, which could have wide benefit because 14 percent of the US adult population has chronic kidney disease. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 3, 2020 Category: Biology Source Type: news

Nigeria: Leptospirosis B - Dr Akinola
[Vanguard] In recent times, the number of people coming down with kidney disease has been on the increase and many reasons have been adduced to explain the rise in number of cases. Chief among the reasons are the rise in cases of diabetes and high blood pressure; which experts say, increase the risk of chronic kidney disease. However, one disease which experts say could lead to kidney failure, respiratory disease, meningitis, liver failure and even death if left untreated, is little known leptospirosis, considered th (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 21, 2020 Category: African Health Source Type: news

The key to the new decade, and a new you
(World Scientific) A search using medical data bases reveals that hundreds of meta-analysis papers conducted with tens of millions of people worldwide have confirmed clinically the efficacies of 30 antioxidant-rich foods to prevent or treat chronic diseases, including hypertension, diabetes, cardiovascular disease, cognitive impairment, chronic kidney disease, cancer, and more. Professor Monte Lai, former professor of biophysics at the Medical College of Wisconsin talks about this and more in his new book 'The Food Cure.' (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 21, 2020 Category: Biology Source Type: news

Moderate Alcohol Consumption Protects Against Kidney Disease Moderate Alcohol Consumption Protects Against Kidney Disease
Those who consume up to 20 drinks per week are less likely to develop chronic kidney disease than never drinkers, but authors warn"potential benefits" of alcohol must be weighed against"harms."Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - January 20, 2020 Category: Transplant Surgery Tags: Nephrology News Source Type: news

Moderate Alcohol Intake Linked to Lower Risk of Kidney Disease Moderate Alcohol Intake Linked to Lower Risk of Kidney Disease
Those who consume up to 20 drinks per week are less likely to develop chronic kidney disease than never drinkers, but authors warn"potential benefits" of alcohol must be weighed against"harms."Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 20, 2020 Category: Cardiology Tags: Nephrology News Source Type: news

Zydus & CMS enter pact for Desidustat in Greater China
The agreement is for Desidustat, a novel oral HIF-PH inhibitor for the treatment of anemia in patients with Chronic Kidney Disease (CKD) not-on-dialysis and for the treatment of anemia CKD patients on dialysis in Greater China, Zydus said in a statement. "Under the license agreement, CMS will pay Zydus an initial upfront payment," it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 20, 2020 Category: Pharmaceuticals Source Type: news

Four months after CEO's death, biotech company names Lilly vet as leader
Enrique Conterno, a 27-year veteran of Eli Lilly and Co., was named Monday as the new CEO of FibroGen Inc., stepping into a role vacated with the death of founder, chairman and CEO Thomas Neff on Aug. 25. The 64-year-old Neff died unexpectedly after the 500-employee San Francisco company he founded in 1993 won its first regulatory approval, for the drug roxadustat, in China. The company also lined up approvals in Japan, Europe and the United States to treat anemia in chronic kidney disease patients ;… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 7, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Four months after CEO's death, biotech company names Lilly vet as leader
Enrique Conterno, a 27-year veteran of Eli Lilly and Co., was named Monday as the new CEO of FibroGen Inc., stepping into a role vacated with the death of founder, chairman and CEO Thomas Neff on Aug. 25. The 64-year-old Neff died unexpectedly after the 500-employee San Francisco company he founded in 1993 won its first regulatory approval, for the drug roxadustat, in China. The company also lined up approvals in Japan, Europe and the United States to treat anemia in chronic kidney disease patients ;… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 7, 2020 Category: Biotechnology Authors: Ron Leuty Source Type: news

Patients with chronic kidney disease could benefit from herbal baths – review
(Natural News) Chinese herbal bath therapy (CHBT) is an ancient method of healing that has been used for thousands of years. Like modern herbal baths, CHBT involves mixing an herbal decoction or herbal extracts in warm bathwater. According to ancient Chinese records, CHBT is an effective treatment for internal diseases like osteoarthritis and skin itching (pruritus) associated... (Source: NaturalNews.com)
Source: NaturalNews.com - December 26, 2019 Category: Consumer Health News Source Type: news

End-Stage Congestive Heart Failure in the Nursing Home Setting
Mrs. D is an 89-year-old African American woman who has moved into the nursing home directly from her home. Her husband became ill and could no longer care for her. She has a history of heart failure and was seeing her cardiologist for weekly weights, but she stopped because she could no longer tolerate the outings. She has had multiple falls at home; most recently, she sustained a left wrist fracture. Her past medical history includes allergic rhinitis, arthritis, esophageal reflux, hyperlipidemia, hypertension, chronic kidney disease, a herniated cervical disc, osteoporosis, and situational depression. (Source: Caring for the Ages)
Source: Caring for the Ages - December 25, 2019 Category: Health Management Authors: Barbara Resnick, Paige Hector Tags: Interdisciplinary Team Case Studies Source Type: news

Potassium Binding for Management of Chronic Kidney Disease Potassium Binding for Management of Chronic Kidney Disease
What benefits might high potassium diets and potassium-binding drugs offer to patients with chronic kidney disease?Current Opinion in Nephrology and Hypertension (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 24, 2019 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Hepatitis gene therapy leads Bay Area trio of year-end FDA approval requests
Approaching the end of long drug-development journeys, these three Bay Area companies formally asked the FDA to approve potential treatments for hemophilia A, anemia in chronic kidney disease patients and migraines. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 23, 2019 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Hepatitis gene therapy leads Bay Area trio of year-end FDA approval requests
Approaching the end of long drug-development journeys, these three Bay Area companies formally asked the FDA to approve potential treatments for hemophilia A, anemia in chronic kidney disease patients and migraines. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 23, 2019 Category: Biotechnology Authors: Ron Leuty Source Type: news

FibroGen Submits New Drug Application to the U.S. FDA for Roxadustat in Patients With Anemia of Chronic Kidney Disease
SAN FRANCISCO, Dec. 23, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:FGEN), today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for roxadustat for the... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - December 23, 2019 Category: Drugs & Pharmacology Source Type: news

Many UK Children With Kidney Disease May Be Prescribed Nephrotoxic Drugs Many UK Children With Kidney Disease May Be Prescribed Nephrotoxic Drugs
Primary care practices in the UK seem to be prescribing nephrotoxic drugs to many children with chronic kidney disease (CKD), a retrospective analysis reveals.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 19, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Potentially Nephrotoxic Meds Prescribed to Children With CKD
THURSDAY, Dec. 12, 2019 -- Potentially nephrotoxic medications are prescribed at a higher rate to children with versus without chronic kidney disease (CKD), according to a study published online Dec. 12 in the Clinical Journal of the American... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 12, 2019 Category: Pharmaceuticals Source Type: news

Researchers create accurate model of organ scarring using stem cells in a lab
Every organ in the body is capable, to some extent, of repairing itself after an injury. As part of this process, scar tissue forms and then recedes to make room for normal tissue when healing is complete.However, when healing is disrupted — whether by chronic injury or disease — the cells that make up scar tissue can go rogue, continuously dividing and spreading until the scar eventually strangles the organ it was intended to help heal, which can lead to organ failure.That progressive, out-of-control scarring is called fibrosis, and it can occur in any organ in the body. Fibrosis plays a major role in many dis...
Source: UCLA Newsroom: Health Sciences - December 11, 2019 Category: Universities & Medical Training Source Type: news

Gadolinium-Based Contrast Safe for Patients With CKD Gadolinium-Based Contrast Safe for Patients With CKD
The risk for nephrogenic systemic fibrosis was low among patients with chronic kidney disease who received a gadolinium-based contrast agent, a study found.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - December 10, 2019 Category: Allergy & Immunology Tags: Nephrology News Source Type: news

Ardelyx Drug Reduces Elevated Phosphate Levels, Late-Stage Study Shows Ardelyx Drug Reduces Elevated Phosphate Levels, Late-Stage Study Shows
Ardelyx Inc's experimental drug has shown promise in a late-stage study as a standalone therapy to reduce elevated blood phosphate levels in patients with chronic kidney disease (CKD), the drugmaker said on Tuesday.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - December 5, 2019 Category: Intensive Care Tags: Nephrology News Source Type: news

Ardelyx drug reduces elevated phosphate levels, late-stage study shows
Ardelyx Inc's experimental drug has shown promise in a late-stage study as a standalone therapy to reduce elevated blood phosphate levels in patients with chronic kidney disease (CKD), the drugmaker said on Tuesday. (Source: Reuters: Health)
Source: Reuters: Health - December 3, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

$2.9 million funds new UIC study on sleep apnea, chronic kidney disease
(University of Illinois at Chicago) Researchers to study sleep apnea and chronic kidney disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 3, 2019 Category: International Medicine & Public Health Source Type: news

ISCHEMIA-CKD PI Hopes Study Doesn't Fuel the Flames of Renalism ISCHEMIA-CKD PI Hopes Study Doesn't Fuel the Flames of Renalism
Principal investigator Sripal Bangalore discusses ISCHEMIA-CKD and its implications for the management of patients with chronic kidney disease and stable CAD.theheart.org on Medscape (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - November 22, 2019 Category: Intensive Care Tags: Cardiology Commentary Source Type: news

The association between chronic kidney disease, falls, and fractures: a systematic review and meta-analysis - Goto NA, Weststrate ACG, Oosterlaan FM, Verhaar MC, Willems HC, Emmelot-Vonk MH, Hamaker ME.
Patients with chronic kidney disease (CKD) are more likely to experience falls and fractures due to renal osteodystrophy and the high prevalence of risk factors for falls. However, it is not well established how great the risk is for falls and fractures fo... (Source: SafetyLit)
Source: SafetyLit - November 18, 2019 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

New Equations Predict Chronic Kidney Disease Risk New Equations Predict Chronic Kidney Disease Risk
Two new equations from the CKD Prognosis Consortium, one for diabetics and one for non-diabetics, accurately predict the risk of developing chronic kidney disease (CKD) over the next five years.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - November 15, 2019 Category: Intensive Care Tags: Nephrology News Source Type: news

Study Finds No Support for Purported Side Effects of PPIs Study Finds No Support for Purported Side Effects of PPIs
Proton-pump inhibitor (PPI) use is not associated with an increased risk of dementia, pneumonia or intestinal infections, and an association with chronic kidney disease (CKD) was likely due to residual confounding, new research suggests.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - November 15, 2019 Category: Intensive Care Tags: Gastroenterology News Source Type: news

The Charlie Brown of Supplements Strikes Out Again The Charlie Brown of Supplements Strikes Out Again
Vitamin D and fish oil fall flat again in type 2 diabetes and chronic kidney disease. But this is not a bad thing, says Dr F. Perry Wilson.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 13, 2019 Category: Consumer Health News Tags: Nephrology Commentary Source Type: news

ASN: Encephalopathy Up in CKD Patients on Higher-Dose Baclofen
WEDNESDAY, Nov. 13, 2019 -- The incidence of encephalopathy is increased with prescription of higher versus lower doses of baclofen among older patients with chronic kidney disease (CKD), according to a study published online Nov. 9 in the Journal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 13, 2019 Category: Pharmaceuticals Source Type: news

New Option for Difficult-to-Treat Uremic Pruritus New Option for Difficult-to-Treat Uremic Pruritus
A kappa opioid receptor agonist is safe and effective for the treatment of pruritus associated with chronic kidney disease, researchers report.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - November 12, 2019 Category: Allergy & Immunology Tags: Nephrology News Source Type: news

Examining muscle relaxant dose, risk of encephalopathy in patients with CKD
(JAMA Network) Whether a higher or lower dose of the muscle relaxant baclofen was associated with 30-day risk of hospitalization with encephalopathy (defined as a main diagnosis of delirium, disorientation, transient alteration of awareness, transient ischemic attack or an unclear diagnosis of dementia) among newly prescribed patients with chronic kidney disease was the focus of this observational study with nearly 16,000 older adults. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 9, 2019 Category: International Medicine & Public Health Source Type: news

ASN: Models Can Predict Risk for Incident Chronic Kidney Disease
FRIDAY, Nov. 8, 2019 -- Risk prediction models have been developed for five-year probability of reduced estimated glomerular filtration rate (eGFR), according to a study published online Nov. 8 in the Journal of the American Medical Association to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 8, 2019 Category: Pharmaceuticals Source Type: news

Predicting risk of chronic kidney disease
(JAMA Network) Data from about 5 million people (with and without diabetes) in 28 countries were used to develop equations to help identify people at increased five-year risk of chronic kidney disease, defined as reduced estimated glomerular filtration rate (eGFR). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 8, 2019 Category: Infectious Diseases Source Type: news

Women Lag Men in Receipt of Kidney Transplants, Dialysis Women Lag Men in Receipt of Kidney Transplants, Dialysis
More men than women get kidney transplants and dialysis even though more women need these treatments for chronic kidney disease, a European study suggests.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - November 5, 2019 Category: Transplant Surgery Tags: Nephrology News Source Type: news

Kidney Swaps Are Revolutionizing a Broken Organ-Donation System in the U.S.
2017 ended as a banner year for my family, but things didn’t look great at the start. A death sentence met us in a boxing ring, and we had to school ourselves on fighting to live. I never thought much about the 37 million American adults who suffer from kidney disease until my husband Neil became one of them. Celebrating our first year of marriage in 2001, we learned by accident through an unrelated medical exam that my husband has polycystic kidney disease, an illness which causes the kidneys to fill with cysts over time, rendering the organs unable to function properly. There is no cure. There was nothing to do but...
Source: TIME: Health - November 5, 2019 Category: Consumer Health News Authors: Lisa Emmott Tags: Uncategorized health Healthcare medicine public health Source Type: news

Women lag men in receipt of kidney transplants, dialysis
(Reuters Health) - More men than women get kidney transplants and dialysis even though more women need these treatments for chronic kidney disease, a European study suggests. (Source: Reuters: Health)
Source: Reuters: Health - November 1, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Revamping the'Renal' Diet Revamping the'Renal' Diet
Diet can play an important role in the prevention and management of chronic kidney disease. Do current dietary recommendations adequately address the issue?Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 31, 2019 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Cardiac Biomarkers May ID High CV Risk in Patients With CKD
MONDAY, Oct. 28, 2019 -- Individuals with chronic kidney disease (CKD) have elevated cardiac biomarkers and are at increased risk for adverse cardiovascular events, according to research published online Oct. 23 in Mayo Clinic Proceedings. Shravya... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 28, 2019 Category: Pharmaceuticals Source Type: news

NASH in Diabetes: New Therapies on the Horizon NASH in Diabetes: New Therapies on the Horizon
With'a host'of treatments in the pipeline, fatty liver disease no longer plays second fiddle to diabetes-related cardiovascular disease and chronic kidney disease, says researcher Gregory Nichols.Medscape Diabetes & Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 23, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology Expert Column Source Type: news

Chronic kidney disease patients at increased risk of adverse cardiovascular outcomes, Mayo Clinic study finds
ROCHESTER, Minn. -- Chronic kidney disease, which afflicts an estimated 6.4% of U.S. adults 45 and older, is associated with an increased risk of heart attack and other adverse cardiovascular outcomes, according to new research from Mayo Clinic. The retrospective review of 1,981 patients who were treated for chronic kidney disease at Mayo Clinic between [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - October 23, 2019 Category: Research Source Type: news

Leafy greens and CKD: Follow a plant-based diet to lower your risk of chronic kidney disease
(Natural News) The consumption of plant-based diets have become more common, and for good reason: Numerous studies have shown that plant foods and plant-based nutrients support overall health in many ways. One study has recently discovered a link between healthy plant-based diets and kidney health. Published in the April 2019 issue of the Clinical Journal... (Source: NaturalNews.com)
Source: NaturalNews.com - October 4, 2019 Category: Consumer Health News Source Type: news

Prescription Opioids Linked to Poor Outcomes in Kidney Patients
THURSDAY, Oct. 3, 2019 -- If you have chronic kidney disease, taking opioids for pain may increase your odds of hospitalization or early death, a new study suggests. The risks were particularly elevated at the highest opioid doses, the researchers... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 3, 2019 Category: General Medicine Source Type: news

Healthy eating tied to lower risk of kidney disease
(Reuters Health) - People with diets rich in fruits, vegetables, whole grains and low-fat dairy may be less likely to develop chronic kidney disease than those who shun these foods in favor of sweets and meats, a research review suggests. (Source: Reuters: Health)
Source: Reuters: Health - October 3, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline
This updated guideline comprises 66 recommendations. The synopsis focuses on 32 key recommendations pertinent to the prevention, diagnosis, treatment, and management of HCV infection in adult CKD populations. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 2, 2019 Category: Consumer Health News Source Type: news

Guideline Recommends Direct-acting Antivirals for HCV in People With Kidney Disease Guideline Recommends Direct-acting Antivirals for HCV in People With Kidney Disease
Patients with chronic kidney disease (CKD) should be screened for hepatitis C virus (HCV) infection, and infected individuals should be treated with direct-acting antiviral (DAA) therapy, according to the updated 2018 Kidney Disease: Improving Global Outcomes (KDIGO) clinical-practice guideline.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - September 25, 2019 Category: Transplant Surgery Tags: Gastroenterology News Source Type: news

Healthy Dietary Patterns Linked to Lower Incidence of CKD
WEDNESDAY, Sept. 25, 2019 -- A healthy dietary pattern is associated with a reduced incidence of chronic kidney disease and albuminuria, according to a review published online Sept. 24 in the Clinical Journal of the American Society of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 25, 2019 Category: Pharmaceuticals Source Type: news

Eating fruit, vegetables and fish 'slashes a person's risk of chronic kidney disease by 30%'
Scientists from Bond University in Australia also found eating well could reduce the risk of albuminuria, an early sign of kidney damage, by 23 per cent. (Source: the Mail online | Health)
Source: the Mail online | Health - September 24, 2019 Category: Consumer Health News Source Type: news